Our Q3 2020 results will be published on November 12th, 2020, at 7 a.m. CEST. Our conference call for the media will take place at 9:30 a.m. CEST, and the conference call for analysts at 2 p.m. CEST.
Welcome to our Investor Relations
5 reasons to invest
We develop products and solutions that make life better – and have been successfully doing so for more than 350 years. And when you’ve prospered for centuries as we have, you must have done a few things right.Read More
Reports & Financials
Merck KGaA, Darmstadt, Germany, keeps growing profitably. The excellent performance of our business shows that we are on the right track. See for yourself in our comprehensive reports and financials.Read More
Our Q4 2020 results will be published on March 4th, 2021, at 7 a.m. CEST. Our conference call for the media will take place at 9:30 a.m. CEST, and the conference call for analysts at 2 p.m. CEST.
Investor Related NewsView All News
MilliporeSigma today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, has been selected as the North American winner of its 2020 Advance Biotech Grant Program
Merck KGaA, Darmstadt, Germany today announced that Dr. Luciano Rossetti, MD, will be retiring as Global Head of Research & Development (R&D) for the Healthcare business sector.
MilliporeSigma has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform
Capital Market DaysLearn More
Capital Market Days
At our Capital Market Days, our shareholders have the opportunity to meet our management and gain insights into our success story. We inform investors about our strategy, the latest financial developments and about our plans for the future.
Webcasts & PresentationsLearn More
Webcasts & Presentations
There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.
Annual General MeetingLearn More
Annual General Meeting
Every year, our shareholders come together to make important decisions on our company’s business. We provide comprehensive material to help them make well-informed voting decisions.